Stay updated on APL-9 in Mild-Moderate ARDS Clinical Trial

Sign up to get notified when there's something new on the APL-9 in Mild-Moderate ARDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-9 in Mild-Moderate ARDS Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.1 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-02T00:15:20.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.1.
    Difference
    0.7%
    Check dated 2025-04-24T17:02:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the study of APL-9 for treating COVID-19 related ARDS, including detailed descriptions of the study's purpose, methodology, and inclusion/exclusion criteria. Additionally, the version number has been updated from v2.14.4 to v2.15.0.
    Difference
    11%
    Check dated 2025-04-17T11:44:39.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.7%
    Check dated 2025-04-10T07:46:19.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    59 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-03-11T08:47:03.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:18:07.000Z thumbnail image

Stay in the know with updates to APL-9 in Mild-Moderate ARDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-9 in Mild-Moderate ARDS Clinical Trial page.